Mediterranean sea bream species—gilthead bream and sea bass—dominate the region's marine aquaculture, with millions of tonnes produced annually. Welfare improvements across this sector affect hundreds of millions of individual fish.
Mediterranean aquaculture produces over 250,000 tonnes of gilthead bream and sea bass combined annually across Turkey, Greece, Spain, and other countries. At typical market sizes of 300-500g, this represents approximately 500-800 million individual fish annually experiencing the production system. The aggregate welfare significance of even modest improvements per individual is enormous at this scale.
Coastal cage systems expose fish to environmental variability throughout the production cycle. Summer temperature extremes in the Mediterranean (above 28°C in shallow coastal areas) cause thermal stress and oxygen depletion events that compromise welfare and cause mortality. Jellyfish blooms damage gills and cause mass mortality in poorly protected cages. Storm events physically damage cage structures and cause fish escape or injury. Environmental monitoring and adaptive management reduce but cannot eliminate these welfare risks.
Ad libitum feeding to apparent satiation, monitored through automatic feedback systems detecting uneaten pellets, maintains fish at appropriate nutritional status without overfeeding or underfeeding. Feed quality—amino acid profile, omega-3 fatty acid content, vitamin levels—directly affects fish health and welfare. Transitioning from fishmeal-dependent formulations to alternative protein sources requires careful nutritional validation to prevent deficiency-related welfare problems.
Mediterranean sea bream production has developed relatively sophisticated veterinary health management in major producing countries. Vaccination programmes against vibriosis and pasteurellosis reduce disease burden; parasite management programmes address Sparicotyle and Diplectanum infestations. EU pharmaceutical regulations govern drug use; certified production requires documented treatment records and compliance with withdrawal periods. Improving diagnostic capacity in smaller producing operations reduces disease burden and improves welfare outcomes.